FOR IMMEDIATE RELEASE: February 11, 2020
ACRP, Pro-ficiency Partnership Signals New Era in Clinical Research Workforce Competency Development
Washington, DC – Clinical research workforce development is taking a major step into the future thanks to a partnership announced today by the Association of Clinical Research Professionals (ACRP) and Pro-ficiency.
The new partnership brings together two of the world’s leading providers of clinical research workforce development solutions, and will empower ACRP to provide a next-generation, competence-based professional development experience to its global network of 50,000-plus clinical research professionals and organizations.
“Despite the important role clinical trials play in the development of new drugs and therapies, our industry has too often and for too long approached workforce development with a ‘check box’ mentality—ensuring compliance with training requirements, but failing to adequately develop competency or raise the standard of clinical trial conduct,” says Jim Kremidas, ACRP Executive Director. “By connecting clinical research professionals and organizations with cutting-edge development programs, this partnership will usher in a new era in workforce development that will fully unlock the potential of our profession.”
The partnership pairs ACRP’s industry-leading training and development programs with Pro-ficiency’s revolutionary compliance management system that reveals key insights into team competency.
“Organizations who partner with ACRP will now have actionable data they can use to assess team competency and to make informed decisions about staff development activities with a rigorous focus on mitigating risk and addressing performance gaps,” Kremidas says.
The Pro-ficiency compliance management system removes the mystery and challenges of staff development. With a user-friendly interface, training administrators can easily manage users, assign and track completion of development programs, and access certificates of completion required for regulatory and protocol compliance. User-specific data provided for each development program provides administrators and leadership with valuable insights into areas for additional training and risk mitigation activities.
ACRP and Pro-ficiency will also collaborate in developing ACRP’s portfolio of competency-based simulation modules that will enable clinical trial staff to master key skills.
“Experiential learning, or learning by doing, is the most effective way to train teams on critical processes and skills. Simulation-based training personalizes the learner experience, improving knowledge acquisition and increasing retention of key learnings,” says JoAnne Schaberick, Co-CEO of Pro-ficiency.
“By leveraging Pro-ficiency’s proven expertise developing practical, application-based learning programs that employ effective, simulation-based training methodologies, ACRP is reinventing traditional online learning in the clinical research enterprise with a focus on true competency development,” Kremidas adds.
ACRP and Pro-ficiency will showcase the power of this new partnership at the 2020 SCOPE conference in Orlando, Florida, February 18-21.
In clinical research, people are everything. ACRP raises clinical research standards and accelerates careers. Better people. Better results. www.acrpnet.org
Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at pro-ficiency.com.
Dave Hadden is an entrepreneur and technology innovator, founding Pro-ficiency and pioneering the fields of A.I.-based medical decision-support, Training Analytics, and Virtual Patient Simulation (VPS). Dave has focused his passion for technological innovation and learning systems in the field of clinical trials, helping sponsors make their studies more accurate and efficient through finding the right technology mix such as virtualization, performance management and applied behavioral sciences to produce the most effective, lasting, and engaging results for clinical trials.